Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch
You may also be interested in...
Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
Roche Diagnostics is expanding its diabetes care portfolio with the acquisition of Medingo Ltd., maker of the Solo micro insulin patch pump, for up to $200 million
Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
Roche Diagnostics is expanding its diabetes care portfolio with the acquisition of Medingo Ltd., maker of the Solo micro insulin patch pump, for up to $200 million
Diabetes Foundation, Device Firms Partner To Develop Artificial Pancreas
The Juvenile Diabetes Research Foundation has begun partnering with device companies to speed the commercialization of artificial pancreas technology that would take some of the guesswork out of diabetes management